Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas.
Paper
Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC
The paper is loaded when this pane is shown.
The authors' code
Markdown · 34 lines · 1.3 KB · GPL
- ## Description ##
- This R package contains additional tools for the analysis of methylation data (Infinium HM-27K and HM-450K).
- * Package: methyltools
- * Type: Package
- * Title: Additional tools for the analysis of methylation data
- * Version: 0.7
- * Date: 2014-06-23
- * Revision: 2016-02-11
- * Author: Pierre Bady <[email hidden]>
- * Maintainer: Pierre Bady <[email hidden]>
- * Depends: R (>= 3.2.2), CGHcall, CGHbase, minfi,preprocessCore, org.Hs.eg.db, TxDb.Hsapiens.UCSC.hg19.knownGene, lumi,mixtools, snowfall,RPMM,ade4
- * Suggests: boot
- * Description: Additional tools for the analysis of methylation data
- * License: GPL (>= 2)
- * URL: http://lausanne.isb-sib.ch/~pbady/Rpackages.html
- Documentation in preparation is available [here](https://github.com/badozor/methyltools/tree/master/trunk/Rdoc).
- ## Licence ##
- GPL version 2 or newer
- ```
- This program is free software; you can redistribute it and/or
- modify it under the terms of the GNU General Public License
- as published by the Free Software Foundation; either version 2
- of the License, or (at your option) any later version.
- This program is distributed in the hope that it will be useful,
- but WITHOUT ANY WARRANTY; without even the implied warranty of
- MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
- GNU General Public License for more details.
- '''
README.md at commit f367260, under GPL · at the source
Overview
- Department of Medical Oncology, Institut Régional du Cancer de Montpellier, University of Montpellier, Montpellier, France
- Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France
- Neuroscience Research Center and Service of Neurosurgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- Translational Data Science Facility, Swiss Institute of Bioinformatics, AGORA Cancer Research Centre, Lausanne, Switzerland
- I2FH, Institut d‘Imagerie Fonctionnelle Humaine, Department of Neuroradiology, Montpellier University Medical Center, Montpellier, France
- Department of Neuroradiology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France
- Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical, Montpellier, France
- L. Lundin and Family Brain Tumor Research Center, Departments of Oncology and Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Abstract
Background: The life expectancy of patients with diffuse IDH-mutant low-grade gliomas (IDHmt LGG) ranges from 5 to over 20 years. Tumor behavior, including spontaneous growth rate, varies even within homogeneously classified subtypes of oligodendroglioma and astrocytoma. Risk-adjusted treatment strategies are needed to avoid therapy-related toxicities without compromising outcome. The spontaneous tumor volume growth rate (TVGR) serves as a prognostic marker and predicts response to therapy. Accurate prediction of TVGR through biomarkers would enable improved evidence-based risk management.
Patients and Methods: A cohort of 77 patients treated in Montpellier, France, for IDHmt LGG grade II (WHO 2016) (29 oligodendrogliomas and 48 astrocytomas) was constituted (age >18 years; MRI scans, frozen tumor tissue). The DNA methylome (Illumina, EPIC array) and transcriptome (RNAseq) were established. TVGR was determined based on serial MRIs collected over the “watch & wait” period before the first treatment beyond surgery. Transcriptomic and methylome data were analyzed for signatures associated with TVGR using rank-rank regression followed by preranked gene set enrichment analysis.
Results: The median TVGR was lower in IDHmt codeleted compared to non-codeleted LGG (0.241 year−1 range 0.082-0.366 vs. 0.424 year−1 range 0.264-0.609, P < .001). In codeleted IDHmt LGG, TVGR was associated with upregulated gene signatures for neuronal systems, synaptic activity, and activation of repressed or poised signatures of neural progenitor cells, while the TVGR in non-codeleted IDHmt LGG was dominated by upregulated proliferation-related signatures, including DNA replication and repair.
Conclusion: Spontaneous TVGR of codeleted and non-codeleted IDHmt LGG involves distinct biological processes, suggesting possible differences in response to therapies.
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Repository
Its files are read in the Code ↔ Paper reader above.
badozor/methyltools
f3672603307115dc72a557f082ca84cfa73dde89, 11 February 2016Availability: 1 check, the latest on 28 September 2026: the link answers
- 28 September 2026: the link answers
1 file
- README.md, Text, 34 lines
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
Datasets cited
- geo:GSE279950, at NCBI GEO; found in “Data Availability”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “DNA Methylome Analyses”
Data Availability
Due to privacy reasons the RNA sequencing data will be made available upon reasonable request under a Data Transfer Agreement. The methylome data from the Montpellier cohort are available under the GEO accession number GSE279950 (https://
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 3 keywords, 18 MeSH terms, 2 funders, 41 references.
Cite
This paper
Darlix, A., Bady, P., Deverdun, J., Bars, E. L., Coget, A., Meriadec, J., Carrière, M., Duffau, H., & Hegi, M. E. (2026). Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas. Neuro-oncology, 28(4), 911-922. https://
BibTeX
@article{darlix2026disti
author = {Darlix, Amélie and Bady, Pierre and Deverdun, Jérémy and Bars, Emmanuelle Le and Coget, Arthur and Meriadec, Justine and Carrière, Mathilde and Duffau, Hugues and Hegi, Monika E},
title = {{Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas}},
journal = {Neuro-oncology},
year = {2026},
month = apr,
volume = {28},
number = {4},
pages = {911--922},
publisher = {Oxford University Press},
issn = {1522-8517},
doi = {10.1093/
url = {https://
pmid = {41460180},
pmcid = {PMC13128452}
}
RIS
TY - JOUR
AU - Darlix, Amélie
AU - Bady, Pierre
AU - Deverdun, Jérémy
AU - Bars, Emmanuelle Le
AU - Coget, Arthur
AU - Meriadec, Justine
AU - Carrière, Mathilde
AU - Duffau, Hugues
AU - Hegi, Monika E
TI - Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas
T2 - Neuro-oncology
J2 - Neuro Oncol
PY - 2026
DA - 2026/
VL - 28
IS - 4
SP - 911
EP - 922
SN - 1522-8517
PB - Oxford University Press
DO - 10.1093/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1093/
"type": "article-journal",
"title": "Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas",
"container-title": "Neuro-oncology",
"author": [
{
"family": "Darlix",
"given": "Amélie"
},
{
"family": "Bady",
"given": "Pierre"
},
{
"family": "Deverdun",
"given": "Jérémy"
},
{
"family": "Bars",
"given": "Emmanuelle Le"
},
{
"family": "Coget",
"given": "Arthur"
},
{
"family": "Meriadec",
"given": "Justine"
},
{
"family": "Carrière",
"given": "Mathilde"
},
{
"family": "Duffau",
"given": "Hugues"
},
{
"family": "Hegi",
"given": "Monika E"
}
],
"container-title-short":
"volume": "28",
"issue": "4",
"page": "911-922",
"DOI": "10.1093/
"PMID": "41460180",
"PMCID": "PMC13128452",
"ISSN": "1522-8517",
"publisher": "Oxford University Press",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
1
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41467-022-28030-3 [code]
- Contribution of the medial eye field network to the voluntary deployment of visuospatial attention.Journal: Nature communicationsIn common: other condition, 1 reference, author Hugues Duffau
- [2] doi:10.1038/s41586-026-10612-6 [code]
- Acquired genetic and cell-state changes in IDH-mutant glioma progression.Journal: NatureIn common: other condition, cellular / molecular, 4 references
- [3] doi:10.1038/s43018-023-00566-3
- Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation.Journal: Nature cancerIn common: genetics / omics, other condition, cellular / molecular, 1 reference, author Monika E Hegi
- [4] doi:10.1016/j.xcrm.2022.100900 [code]
- Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.Journal: Cell reports. MedicineIn common: genetics / omics, other condition, cellular / molecular, 1 reference, author Monika E Hegi
- [5] doi:10.1016/j.xcrm.2026.102682 [code]
- TET CpG sequence-context-specifi
c DNA demethylation shapes progression of IDH-mutant gliomas. Journal: Cell reports. MedicineIn common: genetics / omics, other condition, 3 references - [6] doi:10.1002/1878-0261.13494 [code]
- Epigenetic silencing of HTATIP2 in glioblastoma contributes to treatment resistance by enhancing nuclear translocation of the DNA repair protein MPG.Journal: Molecular oncologyIn common: other condition, author Monika E Hegi
- [7] doi:10.1038/s43856-025-01121-0 [code]
- Integrating direct electrical stimulation with brain connectivity predicts lesion-induced language impairment and recovery.Journal: Communications medicineIn common: other condition, author Hugues Duffau
- [8] doi:10.1002/hbm.26279 [code]
- The central role of the left inferior longitudinal fasciculus in the face-name retrieval network.Journal: Human brain mappingIn common: other condition, author Hugues Duffau
- [9] doi:10.1093/brain/awad402 [code]
- Integrating direct electrical brain stimulation with the human connectome.Journal: Brain : a journal of neurologyIn common: author Hugues Duffau
- [10] doi:10.1111/jcmm.17101
- Genome-wide methylomic analyses identify prognostic epigenetic signature in lower grade glioma.Journal: Journal of cellular and molecular medicineIn common: genetics / omics, other condition, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:82b4d8e7adf3391a…
Add the badge to the code's README
If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.
Markdown
<!-- oscr-badge:start -->
[](https://openscicode.org/badge/doi/10.1093/neuonc/noaf296)
<!-- oscr-badge:end -->reStructuredText
.. oscr-badge:start
.. image:: https://openscicode.org/badge/doi/10.1093/neuonc/noaf296.svg
:target: https://openscicode.org/badge/doi/10.1093/neuonc/noaf296
:alt: OSCR
.. oscr-badge:endHTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1093/neuonc/noaf296"><img src="https://openscicode.org/badge/doi/10.1093/neuonc/noaf296.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".
If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Report a mismatch between the code and the paper · Report a code error (signed in)
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Report a reproduction failure (signed in)
Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
